You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 10, March 10, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Alert me on articles by topic

Optimal Control of Glycemia Among Critically Ill Patients

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Based on their observational study, Dr Finney and colleagues1 speculated that less-stringent control of blood glucose levels suffices to optimize survival among critically ill patients, and that infusing more insulin may actually be harmful. In contrast, our randomized, controlled, intervention study found that intensive insulin therapy to maintain blood glucose levels below 110 mg/dL reduced mortality among critically ill patients.2

We are concerned that the data of Finney et al do not support their speculations. The authors analyzed the relationship between mortality, the time a patient spent in different strata of blood glucose levels, and the amount of insulin infused in each stratum. The logistic regression model, which did not include age, Acute Physiology and Chronic Health Evaluation II (APACHE-II) scores, or Sequential Organ failure Assessment (SOFA) scores, and thus did not correct for these known risk factors, revealed that more infused insulin was associated with increased . . . [Full Text of this Article]

Greet Van den Berghe, MD, PhD
greta.vandenberghe@med.kuleuven.ac.be
Department of Intensive Care Medicine

Roger Bouillon, MD, PhD
Laboratory for Experimental Medicine and Endocrinology
Catholic University of Leuven
Leuven, Belgium


RELATED ARTICLES

Optimal Control of Glycemia Among Critically Ill Patients—Reply
Simon J. Finney and Timothy W. Evans
JAMA. 2004;291(10):1199.
EXTRACT | FULL TEXT  

Glucose Control and Mortality in Critically Ill Patients
Simon J. Finney, Cornelia Zekveld, Andi Elia, and Timothy W. Evans
JAMA. 2003;290(15):2041-2047.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Insulin therapy and acute kidney injury in critically ill patients a systematic review
Thomas et al.
Nephrol Dial Transplant 2007;22:2849-2855.
ABSTRACT | FULL TEXT  

Association of Hypoglycemia, Hyperglycemia, and Glucose Variability With Morbidity and Death in the Pediatric Intensive Care Unit
Wintergerst et al.
Pediatrics 2006;118:173-179.
ABSTRACT | FULL TEXT  

Strict glucose control in the critically ill.
Watkinson et al.
BMJ 2006;332:865-866.
FULL TEXT  

The Evolving Paradigm of Hyperglycemia and Critical Illness
Chinsky
Chest 2004;126:674-676.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.